Ceribell (CBLL) CEO exercises options, files updated Form 4

Rhea-AI Filing Summary

Ceribell, Inc. (CBLL) President, CEO and Director Xingjuan (Jane) Chao reported option exercises and share sales on 11/21/2025. She exercised stock options to acquire 25,000 shares at $2.24 and 25,000 shares at $3.65, then sold 50,000 common shares at a weighted average price of $15.13, with individual trades between $15 and $15.20. The transactions were effected under a Rule 10b5-1 trading plan. Following these trades, she directly owned 798,135 shares and indirectly held 369,088 shares through the ACP 2021 Trust. Her remaining stock options included 27,551 options at $2.24 expiring on June 10, 2029 and 257,100 options at $3.65 expiring on June 10, 2031. The filing also notes a correction to prior reports that had omitted 25,000 shares from earlier option exercises.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chao Xingjuan

(Last) (First) (Middle)

C/O CERIBELL, INC.

360 N. PASTORIA AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		M(1)		25,000	A	$2.24	823,135(7)	D
Common Stock	11/21/2025		M(1)		25,000	A	$3.65	848,135	D
Common Stock	11/21/2025		S(1)		50,000	D	$15.13(2)	798,135	D
Common Stock								369,088	I	By ACP 2021 Trust(3)(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.24	11/21/2025		M(1)			25,000	(5)	06/10/2029	Common Stock	25,000	$0	27,551	D
Stock Option (Right to Buy)	$3.65	11/21/2025		M(1)			25,000	(6)	06/10/2031	Common Stock	25,000	$0	257,100	D

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15 to $15.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.

3. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.

4. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.

5. The stock option is fully vested and currently exercisable.

6. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of June 10, 2021, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

7. The increase in shares beneficially owned reflects the correction of previously filed Forms 4/A filed on September 12, 2025, which added 25,000 shares resulting from option exercises that were inadvertently omitted from earlier reports.

	/s/ Louisa Daniels, Attorney-in-Fact for Xingjuan (Jane) Chao	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.